Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer-Reference-Cited by-同舟云学术

Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer

Published:2017-07 Issue: Volume:101 Page:51-56
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Wariss Bárbara Reis,de Souza Abrahão Karen,de Aguiar Suzana Sales,Bergmann Anke,Thuler Luiz Claudio Santos

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference28 articles.

1. World Health Organization . Health Statistics and Information Systems: WHO Mortality Database. who.int/healthinfo/mortality_ data/. Accessed July 19, 2016.

2. Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil;Guerra;Cad. Saude Publica,2009

3. Determinants of advanced stage presentation of breast cancer in 87, 969 Brazilian women;Abrahão;Maturitas,2015

4. Role of combined sentinel lymph node biopsy and axillary node sampling in clinically node-negative breast cancer;Edwards;Indian. J. Surg.,2015

5. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients;Azab;Ann. Surg. Oncol.,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of pro-inflammatory markers at the preoperative stage in Algerian women with breast cancer;Forum of Clinical Oncology;2024-06-18

2. Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity;Advanced Biology;2024-05-10

3. Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer;Scientific Reports;2023-12-02

4. Neutrophils as potential therapeutic targets for breast cancer;Pharmacological Research;2023-12

5. Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics;The Oncologist;2023-11-16